Melbourne biotech PolyActiva says it hopes to be the next Cochlear by selling its eye drug dispensing system to millions ...

Net loss: €3.06m (loss widened by 60% from 2Q 2024). €0.14 loss per share (further deteriorated from €0.088 loss in 2Q 2024).

WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech”, "Kane” or the "Company”) ...

The current system of specialized institutes at the NIH has led to transformative breakthroughs in cancer therapies, heart ...

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...

SHA-registered beneficiaries will now have full coverage for treatment cycles costing up to Sh700,000 annually.

Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech", "Kane" or the "Company") today announces its first quarter 2025 financial results. First Quarter 2025 ...

Mapmygenome, an AI-driven genomics and personalised health company based in Hyderabad, has acquired Microbiome Insights, a ...

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...

According to a sweeping 2000 analysis by the Centers for Disease Control and Prevention, a range of 2–7 per 1,000, or roughly ...

Crescent Biopharma, Inc. ("Crescent”), a private biotechnology company developing novel precision-engineered molecules ...

WASHINGTON: United States President Donald Trump's administration on Wednesday (May 29) canceled a US$590 million contract ...